DeborahLWolbretteMD

Adult Congenital Heart Disease, Cardiac Electrophysiology

Professor, Medicine, Pennsylvania State University College of Medicine

Dr. Wolbrette is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Texas Health Science Center at HoustonFellowship, Cardiovascular Disease, 1989 - 1992
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1986 - 1989
McGovern Medical School at UTHealthClass of 1986

PubMed

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Bioprosthetic Valves-A Systematic Review and Meta-analysis.
Mohammed Ruzieh, Deborah L Wolbrette, Gerald V Naccarelli
The Journal of Innovations in Cardiac Rhythm Management. 2021-12-01
5 citations
Oral Anticoagulation Use in High-Risk Patients Is Improved by Elimination of False-Positive and Inactive Atrial Fibrillation Cases
Gerald V. Naccarelli, Mohammed Ruzieh, Deborah L. Wolbrette, Mauricio Sendra-Ferrer, John van Harskamp
The American Journal of Medicine. 2021-06-01
8 citations
A Quarter of a Century Later: What is Dofetilide's Clinical Role Today?
Deborah L. Wolbrette, Sarah K. Hussain, Ilir Maraj, Gerald V. Naccarelli
Journal of Cardiovascular Pharmacology and Therapeutics. 2019-01-01

Journal Articles

Original Investigation Editorial Comment Can an Intranasal Calcium-Channel Blocker Convert Paroxysmal Supraventricular Tachycardia and Keep the Doctor Away?∗
Mario D Gonzalez, Gerald V Naccarelli, Deborah L Wolbrette, ScienceDirect